Dr Krishnan Anand, DTech, has been a Senior Lecturer in the Department of Chemical Pathology, Faculty of Health Sciences at the University of the Free State (UFS) since September 2019. Dr Anand also participated in the Future Generation Professoriate Group (FGP) at the UFS. He is an internationally recognised researcher working at the forefront of global health by aligning his research with the United Nations Sustainable Development Goal 3: ‘Ensure healthy lives and promote well-being for all at all ages’, which helps him to produce relevant research and lifesaving 21st-century metabolic medicines. Dr Anand’s passion lies in nanoscience with an emphasis on translational research.
His interdisciplinary work involves the integration of clinical chemistry, medical biochemistry, bioinformatics, and nanobiotechnology into his research, which has allowed him to produce results/literature that is of international quality and standard. Dr Anand leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories, which is currently engaged in biological functions of extracellular vesicles (EVs) in cellular studies conducted under supraphysiological conditions, biomarker discovery through EVs derived from liquid biopsies and the role of circulating biomarkers in disease development. This work is important not only for diagnoses but also for treatment monitoring. Studies are also being conducted in OMICS technologies, epigenetics, toxicology, interpretation of biomolecules by hyphenated techniques, and the recent development of nanosensors in breath biopsy analysis for early and non-invasive disease diagnosis. P-MIND is actively contributing to nanopathology and nanodiagnostics.
From November 2014 to November 2016, Dr Anand served as a Postdoctoral Researcher at the Durban University of Technology (DUT), after which he joined the University of KwaZulu-Natal (UKZN) as a Senior Researcher at the Discipline of Medical Biochemistry and Chemical Pathology from January 2017 to August 2019. In January 2020, he received the prestigious Innovation Postdoctoral Research Fellowship from the Department of Science and Innovation (DSI) and the National Research Foundation (NRF) for his research at the UFS. In 2021, he was awarded the NRF-Y1 rating for Next Generation Researchers and the NRF Y-Rated Incentive Award for Early Career Researchers in 2022.
Dr Anand has received several research grants since he arrived at the UFS, the most significant being a research grant from the Swiss National Science Foundation (SNSF) as the Lead Agency to support his research from 2023 to 2026, and most recently, Technology Innovation Agency (TIA) seed funding for his translational research and the NRF-Y-rated supporting grant from 2023 to 2026. Due to his research and clinical expertise, Dr Anand has 135 research outputs, including several scientific articles in peer-reviewed journals, has authored book chapters, and is the editor of seven books (published by Elsevier, Springer, and Wiley respectively). He holds two patents for his work. Of the aforementioned research outputs, 80% of the publications rank in the top Q1 and Q2 in their respective disciplines, and he has a Google Scholar H-index of 28 and a Scopus H-index of 24. In addition to research, he has successfully supervised and mentored master's and doctoral students and has hosted Postdoctoral Research Fellows.
In the latest list published by Stanford University, Dr Anand was named in the Top 2% of the most infuential scientst worldwide.
As a researcher, Dr Anand has received various awards in academia, such as the Best Postdoctoral Researcher Award (DUT) in 2016, the Young Scientist Award from the Pearl Foundation for Educational Excellence (India) in 2016, and the Top Publisher Award (DUT) in 2017. At the UFS, he is a Faculty of Health Sciences Executive Committee member and serves on the Interdisciplinary Research Evaluation Panel. He is also a reviewer of the NRF Rating Evaluation Applications and Grant Proposals from the Auckland Medical Research Foundation (AMRF –New Zealand).
Dr Anand serves the international scientific community as a review editor of eLife (Africa Region), special issue editor in international peer-reviewed journals, and as an associate editor of Bentham Science Publishers. In addition to this, he belongs to several distinguished societies, such as the American Chemical Society (ACS), the South African Chemical Institute: Professional Chemistry Membership (PrChemSA), the Royal Chemical Society (MRSC), and the International Society for Extracellular Vesicles (ISEV). He was on the advisory board of the International Conference on Nanomedicine (ICON), a Convenor of Advanced Nanomaterials for Energy, Environment and Healthcare Applications (ANEH) and a Bioeconomy Youth Ambassador to the International Advisory Council on Global Bioeconomy (IACGB). Dr Anand’s collaborative network includes (but is not limited to) institutions on a national level such as UKZN, and internationally in India, Australia, China, South Korea, and the United States.